Filters
Other countries
Results: 1 to 19 of 19
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Parietal foramina 2, 609597, Autosomal dominant; PFM2 (Enlarged parietal foramina) (MLPA) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
CGC Genetics Unilabs Portugal | 1 | 1 |
|
ALX4 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 3 | 1 |
|
Invitae Facial Dysostosis and Frontonasal Dysplasia Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 44 | 28 |
|
ALX4-Related Disorders via the ALX4 Gene PreventionGenetics, part of Exact Sciences United States | 3 | 1 |
|
PreventionGenetics, part of Exact Sciences United States | 231 | 139 |
|
Johns Hopkins Genomics DNA Diagnostic Laboratory Johns Hopkins University, School of Medicine United States | 110 | 45 |
|
Craniosynostosis panel. NGS panel of 37 genes. Genologica Medica Spain | 113 | 37 |
|
Panel of facial dysostosis and related disorders. NGS panel of 26 genes. Genologica Medica Spain | 35 | 26 |
|
Skeletal diseases. NGS panel of 169 genes. Genologica Medica Spain | 373 | 169 |
|
Parietal foramina: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 2 | 2 |
|
Facial Dysostosis and Related Disorders NGS Panel Fulgent Genetics United States | 85 | 29 |
|
Fulgent Genetics United States | 339 | 61 |
|
Laboratorio de Genetica Clinica SL Spain | 1 | 1 |
|
Asper Biogene Asper Biogene LLC Estonia | 38 | 24 |
|
Fulgent Genetics United States | 3 | 1 |
|
Fulgent Genetics United States | 5128 | 4672 |
|
Intellectual Disability NGS Panel Fulgent Genetics United States | 1058 | 554 |
|
Results: 1 to 19 of 19
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.